Discussion
A new gene therapy designed to restore frataxin protein to near-normal levels rather than produce excessive amounts improves movement, nerve signaling, and cell health in a mouse model of Friedreich’s ataxia (FA), a study reports. The treatment, called miniFXN7, was delivered in a single injection before symptoms began and used…
